Article Information
Author Information
- Paula A. Rochon, MD, MPH*†‡§¶,
- Geoffrey M. Anderson, MD, PhD†‡**,
- Jack V. Tu, MD, PhD†§¶,
- Jocalyn P. Clark, MSc*,
- Jerry H. Gurwitz, MD††‡‡,
- John Paul Szalai, PhD‡§§¶,
- Paula Lau, MSc†
- From *the Kunin-Lunenfeld Applied Research Unit, Baycrest Centre for Geriatric Care, Toronto, Ont.; †the Institute for Clinical Evaluative Sciences, Toronto, Ont.; ‡the Clinical Epidemiology and Health Care Research Program and the Departments of §Medicine, ¶Public Health Sciences and **Health Administration, University of Toronto, Toronto, Ont.; ††the Meyers Primary Care Institute, Fallon Healthcare System and University of Massachusetts Medical School, Worcester, Mass.; ‡‡the Department of Medicine, University of Massachusetts Medical School, Worcester, Mass.; and §§the Department of Research Design and Biostatistics, Sunnybrook & Women's College Health Sciences Centre, Toronto, Ont.
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Use of β-blocker therapy in older patients after acute myocardial infarction in Ontario
Jump to section
Related Articles
Cited By...
- Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
- Effects of {beta}-Blockers and Anxiety on Complication Rates After Acute Myocardial Infarction
- Integrating pharmacists into family practice teams: Physicians' perspectives on collaborative care
- Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction
- Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction
- Do patients' expectations influence their use of medications?: Qualitative study
- Resting Heart Rate in Cardiovascular Disease
- Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for ST-Elevation Myocardial Infarction
- Corrections